HomeRPRX • NASDAQ
Royalty Pharma plc
add
$35.87
0.00%
Pre-market:(0.33%)-0.12
$35.75
Closed: Jun 30, 8:39:14 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 568.25M | 0.05% |
Operating expense | 161.21M | 177.21% |
Net income | 238.35M | 4,888.47% |
Net profit margin | 41.94 | 4,892.86% |
Earnings per share | 1.06 | 8.07% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.10B | 26.13% |
Total assets | 17.61B | 9.16% |
Total liabilities | 7.82B | 24.77% |
Total equity | 9.79B | — |
Shares outstanding | 421.37M | — |
Price to book | 2.28 | — |
Return on assets | 7.45% | — |
Return on capital | 7.55% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 238.35M | 4,888.47% |
Cash from operations | 596.08M | -10.32% |
Cash from investing | 503.92M | 681.55% |
Cash from financing | -941.30M | -344.01% |
Net change in cash | 158.69M | -56.64% |
Free cash flow | 297.71M | 396.18% |
Previous close
$35.87
Year range
$24.05 - $36.32
Market cap
20.17B USD
Avg Volume
5.55M
P/E ratio
14.63
Dividend yield
2.45%
Primary exchange
NASDAQ
About
Founded
1996
Website
Employees
99
